We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Microplastics and Nanoplastics as Emerging Contributors to Cardiovascular Disease: Mechanisms, Clinical Evidence, and Therapeutic Opportunities
AI summary Read the abstract
Researchers reviewed clinical and mechanistic evidence linking microplastic and nanoplastic exposure to cardiovascular disease, noting that MNPs have been detected in arterial plaques and associated with higher rates of adverse cardiac events, and proposed interaction-based sequestration strategies and lipid nanoparticle therapeutics as potential mitigation avenues.
Microplastics and nanoplastics (MNPs) are increasingly recognized as environmental contaminants with potential cardiovascular relevance. Recent studies have identified MNPs in human blood, arterial tissue, and atherosclerotic plaques, raising concern that chronic exposure may contribute to vascular injury and disease progression. Clinical evidence has reported associations between MNP-positive atherosclerotic plaques and higher observed rates of major adverse cardiovascular events. Building on research concepts initiated in April 2024 (with subsequent proposal activity in May 2024 and July 2024), this perspective reviews key mechanistic and human data relevant to cardiovascular risk. Nanoplastics are not simply smaller microplastics; their greater accessible surface area and higher interactive density may amplify biological reactivity in vascular systems. Interaction-mediated mitigation strategies that promote aggregation or sequestration without polymer degradation are proposed as biologically plausible complements to exposure reduction. Targeted lipid nanoparticle (LNP) delivery of anti-inflammatory and antioxidant compounds may represent a future therapeutic avenue for at-risk populations.
More Papers Like This
Microplastics and Nanoplastics as Emerging Contributors to Cardiovascular Disease: Mechanisms, Clinical Evidence, and Therapeutic Opportunities
AI summary Read the abstract
Researchers review clinical and mechanistic evidence linking microplastics and nanoplastics found in human blood and atherosclerotic plaques to cardiovascular disease, noting that MNP-positive plaques correlate with higher rates of major adverse cardiac events and proposing interaction-mediated sequestration strategies as a potential therapeutic avenue.
Microplastics and Nanoplastics in Cardiovascular Disease: An Emerging Cardiovascular Risk Factor
AI summary Read the abstract
Researchers reviewed mounting experimental and early clinical evidence that microplastics and nanoplastics cross epithelial barriers, accumulate in arterial plaques, cardiac tissue, and thrombi, and trigger oxidative stress and coagulation dysregulation, framing these particles as an emerging cardiovascular risk factor that warrants integration into disease prevention frameworks.
The effects of microplastics and nanoplastics on cardiovascular disease: mechanisms and perspectives
AI summary Read the abstract
This review synthesizes current evidence on how microplastics and nanoplastics (MNPs) may contribute to cardiovascular disease, examining their presence in blood, atherosclerotic plaques, thrombi, and heart tissue. Experimental studies point to oxidative stress, mitochondrial dysfunction, inflammation, and fibrotic remodeling as plausible mechanisms linking MNP exposure to heart disease, though causal relationships in humans remain unproven and standardized detection methods are still lacking.
02 | Micro- and Nanoplastics: a New Unconventional Risk Factor for Cardiovascular Health
AI summary Read the abstract
Researchers reviewed growing clinical and experimental evidence that micro- and nanoplastics can act as non-conventional cardiovascular risk factors, with MNPs detected directly within atherosclerotic plaques where their presence correlates with enhanced inflammatory activity, plaque instability, and worse cardiovascular outcomes—suggesting MNPs amplify established cardiometabolic risks through oxidative stress and endothelial dysfunction.
Evidence, Mechanisms, and Clinical Implications of Microplastics and Nanoplastics As Emerging Cardiovascular Risk Factors: A Narrative Review
AI summary Read the abstract
This review examines growing evidence that micro- and nanoplastics may contribute to cardiovascular health risks, with researchers having found these particles in human artery plaques and blood clots. Evidence indicates that the particles can enter the bloodstream, trigger inflammation, damage blood vessel walls, and potentially increase the risk of heart attacks and strokes. While the evidence is not yet conclusive, the study highlights an emerging area of concern that warrants further investigation into how everyday plastic exposure may affect heart and blood vessel health.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.